Premium
The ARMYDA trials (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) at Campus Bio‐Medico University: rationale, results and future horizons
Author(s) -
Di Sciascio Germano
Publication year - 2007
Publication title -
fundamental and clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.655
H-Index - 73
eISSN - 1472-8206
pISSN - 0767-3981
DOI - 10.1111/j.1472-8206.2007.00539.x
Subject(s) - atorvastatin , angioplasty , medicine , percutaneous coronary intervention , cardiology , reduction (mathematics) , myocardial infarction , mathematics , geometry
Myocardial protection by atorvastation pretreatment was found in several trials applied to percutaneous coronary intervention by the ARMYDA study group. This article reviews those studies and explores future avenues.